Multiorgan thrombotic disorders have been described in a variety of conditions including systemic lupus erythematosus. Among these are the 'catastrophic' antiphospholipid syndrome, disseminated intravascular coagulation and the thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome. In this review we briefly analyse some specific clinical and haematological characteristics of these conditions and attempt to uncover common links between them.
Whitaker AN, Emmerson BTAcute disseminated intravascular coagulation in systemic lupus erythematosus . Aust NZ J Med1972; 2: 182-7.
7.
Shinmyozu K. , Ichinose A., Okad A. et al. A case of systemic lupus erythematosus associated with disseminated intravascular coagulation (DIC). JapJ Med1983; 72: 947-54.
8.
Kerr LD, Spiera H., Aledort LNAcute disseminated intravascular coagulation as a complication of systemic lupus erythematosus. NY State J Med1987; 87: 181-3.
Chillingsworth M., Scott Dgi.Acute systemic lupus erythematosus with fatal pneumonitis and disseminated intravascular coagulation. Ann Rheum Dis1985; 44: 67-9.
11.
Bone R., Francis PB, Pierce A.Intravascular coagulation associated with adult respiratory distress syndrome . Am J Med1976; 61: 585-9.
12.
Cafferata HT , Aggeler PM, Robinson AJ, Blaisdell FWIntravascular coagulation in the surgical patient: its significance and diagnosis. Am J Surg1969; 118: 281-91.
13.
Ruckley CV, Das PC, Leitch AG et al. Serum fibrin/fibrinogen degradation products associated with postoperative pulmonary embolisms and venous thrombosis. Br Med J1970; 4: 395-8.
14.
McKay DG, Franciosi R., Zeller J.Pulmonary embolism and disseminated intravascular coagulation. Am J Cardiol1967; 20: 374-80.
15.
Stahl RB, Javid JP, Lackner H.Unrecognized pulmonary embolism presenting as disseminated intravascular coagulation . Am J Med1984; 76: 772-8.
Bell WR, Braine HG, Ness PM, Kickler TSImproved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med1991; 325: 398-403.
22.
Moake JLThrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome . In: Hoffman R, Benz E, Shattil S, Furie B, Cohen H, eds. Haematology: Basic Principles and Practice. New York: Churchill Livingstone, 1991; 1495-501.
23.
Moake JLTTP-desperation, empiricism, progress. N Engl J Med1991; 325: 426-8.
24.
Byrnes JJ, Moake JLThrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy. Clin Haematol1986; 15: 413-42.
25.
Ramuzzi G.HUS and TTP: variable expression of a single entity. Kidney Int1987; 32: 292-308.
26.
Devinsky O. , Petito CK, Alonso DRClinical and neuro-pathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura. Ann Neurol1988; 23: 380-4.
Rothfield MJSystemic lupus erythematosus: clinical and laboratory aspects. In: McCarty DJ, ed. Arthritis and Allied Conditions . Philadelphia : Lea and Febiger , 1979: 706.
29.
Dekker A., O'Brien ME, Cammorata RJThe association of thrombotic thrombocytopenic purpura with systemic lupus erythematosus. A report of two cases with successful treatment of one . Am J Med Sci1964; 267: 243-9.
30.
Cecere FA, Yoshinoya S., Pope RMFatal thrombotic thrombocytopenia in a patient with systemic lupus erythematosus. Relationship with circulating immune complexes. Arthritis Rheum1981; 24: 550-3.
31.
Finkelstein R., Carter A., Markel A. et al. Plasma infusions in thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus-a successful outcome. Postgrad Med J1982; 56: 577-9.
32.
Gelfand J., Truong L., Stern L. et al. Thrombotic thrombocytopenic purpura syndrome in systemic lupus erythematosus: treatment with plasma infusion. Am J Kid Dis1985; 6: 154-60.
33.
Gatenby P., Smith H., Kirwan P. et al. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura. A case report and review of the relationship. J Rheumatol1981; 8: 504-8. 34. Obeso G., Prieto E., Villalobos E. et al. Púrpura trombocitopénica trombótica en paciente afecto de lupus eritematoso sistémico . Sangre1987; 32: 83-7.
34.
Simeón-Aznar CP, Cuenca-Luque R., Fonollosa-Pla V., Bosch-Gil JAThrombotic thrombocytopenic purpura preceding systemic lupus erythematosus. Ann Rheum Dis1992; 51: 396-8.
35.
Dixit R., Krieg AM, Atkinson JPThrombotic thrombocytopenic purpura developing during pregnancy in a C2-deficient patient with a history of systemic lupus erythematosus. Arthritis Rheum1985; 28: 341-4.
36.
Alpert LIThrombotic thrombocytopenic purpura and systemic lupus erythematosus. Report of a case with immunofluorescence investigation of vascular lesions . Mt Sinai J Med1968; 35: 165-73.
37.
Jain R., Chartash E., Furie R.Systemic lupus erythematosus complicated by thrombotic microangiopathy . Arthritis Rheum1991; 34 (suppl): S93.
38.
Durand JM, Lefevre P., Kaplanski G., Soubeyrand J.Thrombotic microangiopathy and the antiphospholipid antibody syndrome . J Rheumatol1991; 18: 1916-8.
39.
Bird AG, Lendrum R., Asherson RA, Hughes Grv.Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities. Ann Rheum Dis1987 ; 46: 251-5.
40.
Stinson J., Tomkin G., McDonald G. et al. Recurrent disseminated intravascular coagulation and fulminant intrahepatic thrombosis in a patient with the antiphospholipid syndrome. Am J Hematol1990; 35: 281-2.
Kincaid-Smith P.Participation of intra-vascular coagulation in the pathogenesis of glomerular and vascular lesions. Kidney Int1975; 7: 242-53.
43.
Dinour D., Yimmon AM, Slotki JM et al. Postpartum renal failure in systemic lupus erythematosus. Clin Nephrol1990; 34: 152-6.
44.
Collien D.Fibrinolysis: mechanism and clinical aspects. In: Bowie EJM, Sharp AA, eds. Haemostasis and Thrombosis. London: Butterworths, 1985: 237-58.
45.
Awada H., Barlowatz-Meimon G., Dougados M. et al. Fibrinolysis abnormalities in systemic lupus erythematosus and their relationship to vasculitis. J Lab Clin Med1988; 111: 229-36.
46.
Angles-Cano E., Sultan Y., Clauvel JPPredisposing factors to thrombosis in systemic lupus erythematosus. Possible relation to endothehal cell damage. J Lab Clin Med1979; 94: 312-23.
47.
Glas-Greenwalt P., Kant KS, Allen C., Pollak VEFibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus. J Lab Clin Med1984; 104: 962-76.
48.
Tsakiris DA , Marbet GA, Makris PE et al. Impaired fibrinolysis as an essential contribution to thrombosis in patients with lupus anticoagulant . Thromb Haemostas1989; 61: 175-7.
49.
Francis RB, McGehee WG, Feinstein DIEndothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis. Thromb Haemostas1988; 59: 412-4.
50.
Violi F., Ferro D., Valesini G. et al. Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosis. Br Med J1990; 300: 1099-102.
51.
Chu P., Russell NH, Powell RJ et al. Abnormal fibrinolytic activity in systemic lupus erythematosus and possible mechanisms. Br J Rheumatol1988 ; 27: 436-9.
52.
Jaffe EA, Nachman RLSubunit structure of factor VIII antigen synthesized by human endothelial cells. J Clin Invest1975; 56: 698-702.
53.
Bloom AL, Peak IR, Giddings JD et al. Endothelial cells and factor VIII related protein. Lancet1976; i: 46.
54.
Holt CM, Lindsey N., Moult J. et al. Antibody-dependent cellular cytotoxicity of vascular endothelium: characterization and pathogenic associations in systemic sclerosis. Clin Exp Immunol1989; 78: 359-65.
55.
Moore JC, Murphy WG, Kelton JGCalpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Br J Haematol1990; 74: 457-64.
56.
Moake JL, McPherson PDAbnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome. Am J Med1989; 87 (Suppl 3N): 9N-15N.
57.
Karmochkine M., Boffa MC, Piette JC et al. Increase in plasma thrombomodulin in lupus erythematosus with antiphospholipid antibodies. Blood1992; 79: 837-8.
58.
Ishii H.Thrombomodulin. Jpn J Med Technol1989; 38: 1553-9.
59.
Takahashi H. , Hanano N., Wada K. et al. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Haematol1991 ; 38: 174-7.
60.
Cervera R., Khamashta MA, Font J. et al. Antiendothelial cell antibodies in patients with the antiphospholipid syndrome. Autoimmun1991; 11: 1-6.
61.
Burns ER, Zucker-Franklin D.Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells. Blood1982; 60: 1030-7.
